Drug
Blu 701
Blu 701: highest development phase Phase 1, developed by Blueprint Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Blueprint Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| BLU-701 NCT05153408 | Phase 1 | Lung Neoplasm |
Latest
No recent events.
Follow Blu 701 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.